Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

List of Written Confirmation(s) issued for Tox21_300193 Active Pharmaceutical Ingredient (API)

Client Email

Product

Tox21_300193
EU WC

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Tox21_300193

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 7 USDMF, 5 CEP/COS, 1 JDMF, 2 EU WC, 5 NDC API, 4 Listed Suppliers, $ API Reference Price

12 API Suppliers
7 USDMF
5 CEP/COS
1 JDMF
2 EU WC
5 NDC API
4 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

FINISHED DOSAGE FORMULATIONS

154 FDF Dossiers, 61 FDA Orange Book, 19 Europe, 3 Canada, 1 Australia, 56 South Africa, 14 Listed Dossiers

154 FDF Dossiers
61 FDA Orange Book
19 Europe
3 Canada
1 Australia
56 South Africa
14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 50MG;300MG;120MG, TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SYRUP;ORAL - 50MG/5ML

TABLET;ORAL - 50MG;300MG;120MG
TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SYRUP;ORAL - 50MG/5ML

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 12 SPI Pharma, 10 DKSH, 1 Jai Radhe Sales, 4 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 4 Actylis, 2 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 7 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 26 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 18 Microlex e.U, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 27 Roquette, 2 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 1 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 6 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

82 Fillers, Diluents & Binders, 37 Direct Compression, 30 Disintegrants & Superdisintegrants, 28 Thickeners and Stabilizers, 24 Lubricants & Glidants, 23 Granulation, 20 Coating Systems & Additives, 20 Co-Processed Excipients, 16 Film Formers & Plasticizers, 14 Solubilizers, 13 Controlled & Modified Release, 13 Taste Masking, 12 Parenteral, 8 Chewable & Orodispersible Aids, 8 Empty Capsules, 7 Topical, 6 Emulsifying Agents, 5 Rheology Modifiers, 3 Coloring Agents, 3 API Stability Enhancers, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

82 Fillers, Diluents & Binders
37 Direct Compression
30 Disintegrants & Superdisintegrants
28 Thickeners and Stabilizers
24 Lubricants & Glidants
23 Granulation
20 Coating Systems & Additives
20 Co-Processed Excipients
16 Film Formers & Plasticizers
14 Solubilizers
13 Controlled & Modified Release
13 Taste Masking
12 Parenteral
8 Chewable & Orodispersible Aids
8 Empty Capsules
7 Topical
6 Emulsifying Agents
5 Rheology Modifiers
3 Coloring Agents
3 API Stability Enhancers
1 Soft Gelatin
1 Surfactant & Foaming Agents

DIGITAL CONTENT

9 NEWS #PharmaBuzz

9 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 22 Finished Drug Prices

1 US Medicaid Prescriptions
22 Finished Drug Prices

MARKET PLACE

12 APIs, 5 FDF Dossiers

12 APIs
5 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

1 EDQM
1 USP
1 Others

ANALYTICAL

2 Analytical Methods

2 Analytical Methods

$ API Ref.Price (USD/KG) : 18 Xls

Filters

Reset all filters

Filters

FILTER :

filter Name of the Firm Reset all filters

2 All

01 1M/s. Amsal Chem Pvt., Ltd.,

02 1M/s. Calyx Chemicals and Pharmaceuticals Ltd.,

filter Product Name Reset all filters

2 All

01 1Isoniazid (BP/ EP/USP)

02 1Isoniazid (BP/EP/USP)

filter WC Number Reset all filters

2 All

01 1WC-0088

02 1WC-0172

filter Country Reset all filters

2 All

01 2India

API Suppliers
USDMF
CEP/COS
JDMF
EU WC
NDC API
Listed Suppliers

List of Suppliers

Product Main Page

01

Amsal Chem Private Ltd.

AAPS 2024

Not Confirmed

Amsal Chem Private Ltd.

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Isoniazid (BP/EP/USP)

Date of Issue : 2019-10-30

Valid Till : 2022-10-31

Written Confirmation Number : WC-0172

Address of the Firm : A-1, 401, 402 & 403 GIDC Ankleshwar, Bharuch India

Product Web Link

Digital Content

Corporate PDF

02

Calyx Chemicals & Pharmaceuticals Limited

AAPS 2024

Not Confirmed

Calyx Chemicals & Pharmaceuticals Limited

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Isoniazid (BP/ EP/USP)

Date of Issue : 2019-09-09

Valid Till : 2022-09-08

Written Confirmation Number : WC-0088

Address of the Firm : N-102/91, MIDC, Tarapur, Boisar, Dist. Thane-401 506

Product Web Link

Digital Content

Corporate PDF

Tox21_300193 Manufacturers | Traders | Suppliers

Tox21_300193 Manufacturers, Traders, Suppliers 1

16

We have 2 companies offering Tox21_300193

Get in contact with the supplier of your choice:

Amsal Chem Private Ltd.
Calyx Chemicals & Pharmaceuticals Limited

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?